Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Poult Sci ; 103(4): 103501, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38350386

RESUMEN

Previous studies have shown that avian hepatitis E virus (HEV) decreases egg production by 10-40% in laying hens, but have not fully elucidated the mechanism of there. In this study, we evaluated the replication of avian HEV in the ovaries of laying hens and the mechanism underlying the decrease in egg production. Forty 150-days-old commercial laying hens were randomly divided into 2 groups of 20 hens each. A total of 1 mL (104GE) of avian HEV stock was inoculated intravenously into each chicken in the experimental group, with 20 chickens in the other group serving as negative controls. Five chickens from each group were necropsied weekly for histopathological examination. The pathogenicity of avian HEV has been characterized by seroconversion, viremia, fecal virus shedding, ovarian lesions, and decreased egg production. Both positive and negative-strand avian HEV RNA, and ORF2 antigens can be detected in the ovaries, suggesting that avian HEV can replicate in the ovaries and serve as an important extrahepatic replication site. The ovaries of laying hens underwent apoptosis after avian HEV infection. These results indicate that avian HEV infection and replication in ovarian tissues cause structural damage to the cells, leading to decreased egg production.


Asunto(s)
Virus de la Hepatitis E , Hepevirus , Quistes Ováricos , Neoplasias Ováricas , Enfermedades de las Aves de Corral , Animales , Femenino , Pollos , Quistes Ováricos/veterinaria , Neoplasias Ováricas/veterinaria , Hepevirus/genética , Apoptosis
2.
Sci Total Environ ; 884: 163794, 2023 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-37127154

RESUMEN

MODIS and VIIRS aerosol products have been used extensively by the scientific community. Products in operation include MODIS Dark Target (DT), Deep Blue (DB), and Multi-Angle Implementation of Atmospheric Correction (MAIAC) and VIIRS DT, DB, and NOAA Environmental Data Record products. This study comprehensively validated and inter-compared aerosol optical depth (AOD) and Ångstrom exponent (AE) over land and the ocean of these six products (seven different algorithms) on regional and global scales using AErosol RObotic NETwork (AERONET) and Maritime Aerosol Network (MAN) observations. In particular, we used AERONET inversions to classify AOD and AE biases into different scenarios (depending on absorption and particle size) to obtain retrieval error characteristics. The spatial patterns of the products and their differences were also analyzed. Collectively, although six satellite AODs are in good agreement with ground observations, VIIRS DB (land and ocean) and MODIS MAIAC (land only) AODs show better validation metrics globally and better performance in 8/10 world regions. Therefore, they are more recommended for usage. Although land AE retrievals are not capable of quantitative application at both instantaneous and monthly scales, their spatial patterns show qualitative potential. Ocean AE shows a relatively high correlation coefficient with ground measurements (>0.75), meeting the fraction of expected accuracy (> 0.70). Error characteristic analyses emphasize the importance of aerosol particle size and absorption-scattering properties for land retrieval, indicating that improving the representation of aerosol types is necessary. This study is expected to facilitate the usage selection of operating VIIRS and MODIS products and their algorithm improvements.


Asunto(s)
Contaminantes Atmosféricos , Contaminación del Aire , Humanos , Contaminantes Atmosféricos/análisis , Contaminación del Aire/análisis , Monitoreo del Ambiente , Aerosoles/análisis , Océanos y Mares
3.
Graefes Arch Clin Exp Ophthalmol ; 261(7): 1811-1822, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-36617582

RESUMEN

PURPOSE: To apply propensity score matching to evaluate the impact of peripapillary staphylomas (PPS) on vascular and structural characteristics in the myopic eyes. METHODS: This was a prospective, cross-sectional study. Forty-one control eyes and 41 eyes with PPS were analyzed. The eyes were selected using propensity score matching analysis based on the age and axial length. All subjects underwent ophthalmologic examinations for assessing vessel and structure parameters using swept-source optical coherence tomography (SS-OCT), OCT angiography, color fundus photography, and ocular biometry. RESULTS: As compared with control eyes, the eyes with PPS had shallower anterior chamber depth (3.61 ± 0.24 mm vs 3.77 ± 0.24 mm, P = 0.004), higher intraocular pressure (IOP) (16.59 ± 2.88 mmHg vs 14.53 ± 2.45 mmHg, P = 0.002), and higher myopic spherical equivalent (- 11.52 ± 3.22D vs - 9.88 ± 2.20D, P = 0.009). while corneal curvature and lens thickness between the two groups were not statistically different. Compared with control eyes, increased macular deep vessel density, reduced macular choriocapillaris and radial peripapillary capillary, and thinning retinal layer, ganglion cell complex, choroidal layer as well as the superior and inferior peripapillary retinal nerve fiber layer were observed in eyes with PPS, apart from larger disc area, parapapillary atrophy area, and degree of disc rotation. Logistic regression analysis revealed that the IOP (P = 0.046), disc rotation (P = 0.003), and average peripapillary choroidal thickness (P = 0.009) were associated with the presence of PPS. CONCLUSION: Close association of PPS with exacerbation of myopia and anatomical alterations was observed which not only affected the eye posterior segment but also the anterior segments. We further identified significant reductions in the radial peripapillary capillary and macular choroidal perfusion with the increase in macular deep retinal flow blood of myopic eyes with PPS. Higher IOP, thinner peripapillary choroidal thickness, and rotated optic disc were risk factors for the presence of PPS.


Asunto(s)
Miopía , Disco Óptico , Humanos , Estudios Transversales , Estudios Prospectivos , Puntaje de Propensión , Miopía/complicaciones , Miopía/diagnóstico , Disco Óptico/irrigación sanguínea , Tomografía de Coherencia Óptica/métodos
4.
Dis Markers ; 2022: 5038847, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36051361

RESUMEN

Objective: Elevated intraocular pressure (IOP) has significant impacts on different stages in the progression of chronic glaucoma. In this study, we investigated changes in the material properties of sclera and lamina cribrosa (LC) in a nonhuman primate model with elevated IOP. Methods: Normal adult Tibetan macaques were selected for the construction of elevated IOP model. After 40 days of stable maintenance on the ocular hypertension, the binocular eyeballs were obtained for the measurement of macroscopic parameters of the eyeballs. Posterior scleral tissue strips were obtained in circumferential and axial directions, and thickness was measured, respectively. Biomechanical parameters were obtained with stress relaxation, creep, and tensile test. The nanoindentation test was performed on the LC and scleral tissue around optic nerve head (ONH) to obtain compressive modulus. Results: In the presence of elevated IOP, variations of the axial diameter of the eyeball were greater than those of the transverse diameter, and the mean scleral thickness around ONH was smaller in the experimental group than control group. The elastic modulus and stress relaxation modulus of sclera were larger, and the creep rate was lower in the experimental group than control group. In the control group, the elastic modulus and stress relaxation modulus of the circumferential sclera were larger in the axial direction, and creep rate was smaller. In the experimental group, there was no significant difference in biomechanical characteristics between the two directions. Compared to the control group, the compression modulus of the LC was smaller, and the compression modulus of sclera around ONH was larger in the experimental group. Conclusion: Elevated IOP alters the viscoelasticity and anisotropy of sclera and LC. These may contribute to reduction of the organizational resistance to external forces and decline in the ability of self-recovery.


Asunto(s)
Glaucoma , Disco Óptico , Animales , Fenómenos Biomecánicos/fisiología , Haplorrinos , Presión Intraocular , Disco Óptico/fisiología , Esclerótica/fisiología
5.
Biomacromolecules ; 23(10): 4053-4062, 2022 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-36113205

RESUMEN

The cell walls of parenchyma cells and fibers in bamboo are both highly lignified with secondary thickening. However, the former were found to have much higher nanofibrillation efficiency than fibers via both protocols of ultrasonication and high pressure homogenization. To elucidate the inherent mechanism, detailed comparisons of chemical composition, cell morphology, cell wall density, pore structures, and structural organization of cell wall polymers were performed on native and pretreated cell walls of both parenchyma cells and fibers. Chemical compositional analysis showed that fibers have much higher cellulose (49.8% to 35.5%) but lower xylan content (21.1% to 36.2%) than parenchyma, while their lignin contents were similar (24.9% vs 22.9%). Polarized FTIR further revealed clear differences in the structural organization of polymers between the two types of cells, with all the polymers of fibers being more orderly assembled than those of parenchyma cells. The compact arrangement of polymers in the fibers was also supported by the much higher cell wall density (1.52 vs 1.28 g/cm3) and lower porosity (0.007 vs 0.013 cc/g after chemical pretreatments), as compared to the parenchyma cells. The study provides evidence that the anatomical characteristics of huge cavity-wall ratio, higher cell wall porosity, and less ordered arrangement of cell wall matrix polymers (mainly lignin) in parenchyma cells contribute to their higher nanofibrillation efficiency compared to fibers.


Asunto(s)
Lignina , Xilanos , Pared Celular/química , Celulosa/metabolismo , Lignina/metabolismo , Xilanos/metabolismo
6.
BMC Ophthalmol ; 22(1): 72, 2022 Feb 12.
Artículo en Inglés | MEDLINE | ID: mdl-35151269

RESUMEN

BACKGROUND: ß-Zone parapapillary atrophy (ß-PPA) is a common sign in patients with open-angle glaucoma (OAG). Some studies have suggested that ß-PPA can aid in the diagnosis of OAG. We performed a systematic review and meta-analysis of the prevalence and diagnostic ability of ß-PPA in OAG. METHODS: We performed a literature search in PubMed, Web of Science, Embase and Google Scholar from inception to 1st November, 2021. Both hospital-based and population-based studies that reported details of ß-PPA in OAG were included. RESULTS: We screened 1404 articles from these databases and ultimately included 24 articles in our meta-analysis. The prevalence of ß-PPA in OAG was 0.73 (95% CI 0.67 to 0.78). The results of subgroup analysis by country revealed prevalence rates of 0.83 (95% CI 0.78 to 0.88) in Japan, 0.85 (95% CI 0.64 to 0.97) in Korea, 0.64 (95% CI 0.55 to 0.73) in the USA, 0.61 (95% CI 0.58 to 0.63) in Germany and 0.57 (95% CI 0.39 to 0.74) in China. Fundus photography, Heidelberg retina tomography (HRT), Heidelberg retina angiography (HRA) + indocyanine green angiography (ICGA), Spectral domain optical coherence tomography (SD-OCT)and Swept source optical coherence tomography(SS-OCT) values were 0.65 (95% CI 0.58 to 0.71), 0.70 (95% CI 0.50 to 0.86), 0.78 (95% CI 0.61 to 0.91), 0.77 (95% CI 0.65 to 0.88) and 0.99(95% CI 0.87 to 1.00) respectively. The sensitivity and specificity of ß-PPA as a diagnostic marker were 0.78 (95% CI 0.68 to 0.85) and 0.63 (95% CI 0.51 to 0.73), respectively. CONCLUSIONS: ß-PPA is a potential diagnostic marker for OAG. However, a more detailed understanding of ß-PPA characteristics is needed to improve the ability to predict OAG.


Asunto(s)
Glaucoma de Ángulo Abierto , Atrofia Óptica , Disco Óptico , Atrofia/patología , Glaucoma de Ángulo Abierto/diagnóstico , Glaucoma de Ángulo Abierto/epidemiología , Glaucoma de Ángulo Abierto/patología , Humanos , Presión Intraocular , Atrofia Óptica/diagnóstico , Atrofia Óptica/epidemiología , Disco Óptico/patología , Prevalencia , Tomografía de Coherencia Óptica
7.
BMC Ophthalmol ; 22(1): 28, 2022 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-35034608

RESUMEN

BACKGROUND: Aniridia is a congenital, panocular disease that can affect the cornea, anterior chamber angle, iris, lens, retina and optic nerve. PAX6 loss-of-function variants are the most common cause of aniridia, and variants throughout the gene have been linked to a range of ophthalmic abnormalities. Furthermore, particular variants at a given site in PAX6 lead to distinct phenotypes. This study aimed to characterize genetic variants associated with congenital aniridia in a Chinese family. METHODS: The proband and family underwent ophthalmologic examinations. DNA was sampled from the peripheral blood of all 6 individuals, and whole-exome sequencing was performed. Sanger sequencing was used to verify the variant in this family members. RESULTS: A novel variant (c.114_119delinsAATTTCC: p.Pro39llefsTer17) in the PAX6 gene was identified in subjects II-1, III-1 and III-2, who exhibited complete aniridia and cataracts. The proband and the proband's brother also had glaucoma, high myopia, and foveal hypoplasia. CONCLUSIONS: We identified that a novel PAX6 frameshift heterozygous deletion variant is the predominant cause of aniridia in this Chinese family. TRIAL REGISTRATION: We did not perform any health-related interventions for the participants.


Asunto(s)
Aniridia , Aniridia/genética , China/epidemiología , Proteínas del Ojo/genética , Heterocigoto , Humanos , Masculino , Mutación , Factor de Transcripción PAX6/genética , Linaje
8.
Graefes Arch Clin Exp Ophthalmol ; 259(12): 3805-3814, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34244823

RESUMEN

PURPOSE: To identify the potential genes in human trabecular meshwork (TM) related to primary open-angle glaucoma (POAG). METHODS: First, long noncoding RNA (LncRNA) and mRNA expression profiles in TM samples from 4 control subjects and 4 POAG patients were accessed by microarray analyses. Then, twenty lncRNAs were validated by real-time quantitative PCR in the same samples from microarray analyses. Finally, eight highly expressed lncRNAs were further tested by real-time quantitative PCR in TM from 8 normal controls and 19 POAG patients. Expression data were normalized and analyzed using the R software. Pathway analyses were performed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. RESULTS: A total of 2179 lncRNAs and 923 mRNAs in the TM of POAG patients were significantly upregulated, and 3111 lncRNAs and 887 mRNAs were significantly downregulated. ENST00000552367, ENST00000582505, ENST00000609130, NR_029395, NR_038379, and ENST00000586949 expression levels were significantly higher in the TM from a different cohort of POAG patient than normal controls. CONCLUSION: ENST00000552367, ENST00000582505, ENST000006091- 30, NR_029395, NR_038379, and ENST00000586949 may play essential roles in the development of POAG.


Asunto(s)
Glaucoma de Ángulo Abierto , ARN Largo no Codificante , Perfilación de la Expresión Génica , Glaucoma de Ángulo Abierto/diagnóstico , Glaucoma de Ángulo Abierto/genética , Humanos , ARN Largo no Codificante/genética , ARN Mensajero/genética , Malla Trabecular
9.
J Ophthalmol ; 2021: 5586719, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34123413

RESUMEN

AIM: Within the clinical setting, some patients have been identified as lacking in response to PGAs. This meta-analysis study aimed to evaluate the responsiveness of latanoprost, travoprost, bimatoprost, and tafluprost in OAG/OHT patients, latanoprost nonresponders (LNRs), and the IOP-reducing efficacy and safety. METHODS: A literature search was conducted on PubMed, Embase, and the Cochrane Controlled Trials Register. The primary clinical endpoint was the number of responders at the end of the study. The secondary clinical endpoint was the IOP reduction at the endpoint from baseline. Safety evaluation included five common adverse events: conjunctival hyperemia, hypertrichosis, ocular burning, ocular itching, and foreign-body sensation. RESULTS: Eleven articles containing ten RCTs were included in this meta-analysis study. The results highlighted that, in the OAG/OHT population, there was no statistically significant difference in the responsiveness of the four PGAs. Bimatoprost had a better IOP-reducing efficacy than latanoprost. There was no significant difference in the IOP-reducing efficacy of travoprost, latanoprost, and tafluprost. In LNRs, the responsiveness of bimatoprost, travoprost, and latanoprost did not show statistical differences. Bimatoprost reduced IOP with a greater extent than latanoprost and travoprost in LNRs, while there was no significant difference in the IOP-reducing efficacy of travoprost and latanoprost. No serious adverse events occurred with the treatment of the four PGAs. The prevalence of conjunctival hyperemia due to bimatoprost or tafluprost was significantly higher than that of latanoprost. Other adverse events had no significant difference between the four drugs. CONCLUSION: The existing studies cannot prove that latanoprost, travoprost, bimatoprost, and tafluprost have different responsiveness in OAG/OHT patients. Switching to bimatoprost or travoprost cannot achieve a significant improvement in responsiveness in LNRs. Bimatoprost has a better IOP-reducing efficacy than latanoprost and travoprost. No serious adverse events occurred during treatment with any medication we studied.

10.
Graefes Arch Clin Exp Ophthalmol ; 259(8): 2119-2130, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33404680

RESUMEN

OBJECTIVE: To investigate the microvasculature and structural characteristics of the eyes of myopic patients and their association with posterior staphyloma (PS). METHODS: This was a retrospective, case-control study comprising of 106 eyes from 72 individuals. Using 1:1 matching of axial length (AL) of their eyes, patients were allocated into a PS group or no posterior staphyloma (NPS) group. All patients were examined using ultra-widefield fundus imaging, optical coherence tomography angiography, and ocular biometry to acquire microvasculature and microstructure parameters. RESULTS: The anterior chamber depth (ACD) of the PS group was significantly different from that of the NPS group (3.56 mm vs 3.76 mm, P < 0.001), as was 1ens thickness (3.72 mm vs 3.57 mm, P = 0.005) and spherical equivalent (SE)(-10.11D vs -8.80D, P = 0.014). The PS group had reduced choriocapillaris flow, subfoveal choroidal thickness (SFCT), and a thinner retinal layer compared with the NPS group. No difference in retinal blood flow between the two groups was observed. The PS group exhibited a smaller disc area (15082.89 vs 17,043.32, P = 0.003) and angle α between temporal retinal arterial vascular arcades (113.29°vs 128.39°, P = 0.003), a larger disc tilt ratio (1.41 vs 1.24, P < 0.001) and parapapillary atrophy (PPA) area (13840.98 vs 8753.86, P = 0.020), compared with the NPS group. Multivariate regression analysis indicated that disc tilt ratio (P = 0.031) and SFCT (P = 0.015) were significant predictors of PS. In addition, PS (P = 0.049), AL (P = 0.003), corneal refractive power (P < 0.001), ACD (P = 0.022), relative lens position (P = 0.045), and disc area (P = 0.011) were significant predictors of SE. CONCLUSIONS: PS was found to be closely linked to a reduction in choriocapillaris perfusion and anatomical abnormalities including posterior and anterior segments. Furthermore, PS exacerbated the progression of myopia.


Asunto(s)
Miopía , Enfermedades de la Esclerótica , Estudios de Casos y Controles , Humanos , Microvasos , Miopía/diagnóstico , Estudios Retrospectivos , Enfermedades de la Esclerótica/diagnóstico , Tomografía de Coherencia Óptica
11.
Int Ophthalmol ; 41(4): 1503-1511, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33492563

RESUMEN

PURPOSE: Axenfeld-Rieger syndrome (ARS) is an autosomal dominant disorder characterized by ocular anterior segment abnormalities. In the current study, we describe clinical and genetic findings in a Chinese ARS pedigree. METHODS: An ARS pedigree was recruited and patients were given comprehensive ophthalmic examinations and general physical examinations. DNA from the proband II:2 was used for exome sequencing. Sanger sequencing was utilized to identify and validate PITX2 variations. qPCR and western blotting were performed to detect PITX2 expression in immortalized peripheral blood lymphocytes. RESULTS: All affected family members showed typical ocular abnormalities, including iris atrophy, corectopia, shallow anterior chamber, complete or partial angle closure, and advanced glaucoma. They also exhibited systemic anomalies, such as microdontia, hypodontia, and redundant periumbilical skin. A heterozygous splice-site variation c.390 + 1G > A in PITX2, which might lead to a truncated PITX2 protein (p.Val131IlefsX127), was found in the proband. Sanger sequencing validated that the variation completely co-segregated with the ARS phenotype within this family and was absent in 100 unrelated controls. Western blotting revealed that the nuclear PITX2 protein was significantly decreased in patients compared with controls. Nonetheless, there was no significant difference in the total PITX2 protein level, consistent with qPCR results showing no alteration in PITX2 mRNA levels in the patient group. CONCLUSIONS: PITX2 c.390 + 1G > A (p.Val131IlefsX127) was a novel genetic etiology of the ARS pedigree. The mutation leads to decreased nuclear PITX2, indicating lower transcriptional activity.


Asunto(s)
Anomalías del Ojo , Enfermedades Hereditarias del Ojo , Proteínas de Homeodominio/genética , Factores de Transcripción/genética , Segmento Anterior del Ojo/anomalías , Anomalías del Ojo/diagnóstico , Anomalías del Ojo/genética , Enfermedades Hereditarias del Ojo/genética , Humanos , Mutación , Proteínas Nucleares , Linaje , Proteína del Homeodomínio PITX2
12.
Drug Deliv ; 26(1): 812-819, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31389267

RESUMEN

The aim of this study is to investigate the effects and toxicities of poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV)-loading rosiglitazone on preventing scar formation after glaucoma filtration surgery (GFS) in the rabbit model. Rosiglitazone/PHBV drug delivery system was prepared via electrospinning. Release behavior of RSG/PHBV membrane was evaluated by high-performance liquid chromatography. The different concentration membranes were implanted under the conjunctiva of the rabbit's eyes (RSG/PHBV groups). Also, MMC-soaked sponges were placed under the conjunctiva of the eyes (positive group) for 3 min. Intraocular pressures and bleb features were then assessed for 4 weeks postoperative. Bleb sections were stained with HE, Masson's trichrome and α smooth muscle action (αSMA) immunohistochemistry. The protein expression of collagen I, αSMA, and connective tissue growth factor in the bleb area were then quantified. The following results were observed: (1) the concentration of rosiglitazone would not affect the morphology of RSG/PHBV membrane. (2) RSG/PHBV membrane would effective and safety prevent the formation of fibrosis after GFS in the rabbit model. Implantation of RSG/PHBV membrane prevents scar formation after GFS. What's more, it ameliorated toxicity to conjunctiva and cornea compared with the placement of MMC. The RSG/PHBV membrane would be a more effectivity and safer strategy than MMC.


Asunto(s)
Fibrosis/tratamiento farmacológico , Glaucoma/tratamiento farmacológico , Poliésteres/administración & dosificación , Rosiglitazona/administración & dosificación , Animales , Cicatriz/tratamiento farmacológico , Conjuntiva/efectos de los fármacos , Córnea/efectos de los fármacos , Modelos Animales de Enfermedad , Sistemas de Liberación de Medicamentos/métodos , Cirugía Filtrante/métodos , Presión Intraocular/efectos de los fármacos , Conejos , Cicatrización de Heridas/efectos de los fármacos
13.
Invest Ophthalmol Vis Sci ; 60(7): 2743-2752, 2019 06 03.
Artículo en Inglés | MEDLINE | ID: mdl-31247081

RESUMEN

Purpose: To evaluate the potential antifibrotic effect of rosiglitazone (RSG), a peroxisome proliferator-activated receptor γ (PPARγ)-selective agonist, on subconjunctival fibrosis in a rabbit model of glaucoma filtration surgery (GFS) in vivo, and to investigate the underlying mechanisms in human Tenon's fibroblasts (HTFs) in vitro. Methods: GFS were performed on adult male New Zealand white rabbits with chronic ocular hypertension previously established by injections of 2% methylcellulose into the anterior chamber. Rabbits were treated by RSG, mitomycin C (MMC) or 5-fluorouracil (5-FU) intraoperatively. The morphology of filtering blebs was evaluated by Indiana Bleb Appearance Grading Scale (IBAGS) scoring. Expression of profibrotic genes was determined by quantitative PCR, immunoblot, and/or histochemical analysis. In vitro studies were performed in a transforming growth factor (TGF)-ß1-based cell model of fibrosis. Autophagy was evaluated by the formation of autophagosomes and autolysosomes using fluorescent and transmission electron microscopy and by expression of key mediators in the autophagic pathway. Results: RSG treatment ameliorated a rebound intraocular pressure (IOP) elevation, prolonged the survival of filtering blebs, and attenuated subconjunctival fibrosis in rabbits following trabeculectomy. Pretreatment of HTFs with RSG inhibited TGF-ß1-induced expression of profibrotic genes encoding specificity protein 1, connective tissue growth factor, and α smooth muscle actin. RSG augmented TGF-ß1-induced autophagy in HTFs via a beclin1/VPS34-dependent mechanism. Augmentation of autophagy is associated with inhibition of TGF-ß1-induced profibrotic gene expression by RSG. Conclusions: RSG treatment prevents subconjunctival fibrosis after GFS by inhibition of profibrotic gene expression through a mechanism involved in promoting autophagy in local fibroblasts. RSG represents a novel antifibrotic drug with the potential to improve the success rate of GFS.


Asunto(s)
Conjuntiva/efectos de los fármacos , Modelos Animales de Enfermedad , Glaucoma/cirugía , Hipoglucemiantes/uso terapéutico , Complicaciones Posoperatorias/prevención & control , Rosiglitazona/uso terapéutico , Trabeculectomía , Actinas/metabolismo , Animales , Autofagia , Western Blotting , Conjuntiva/metabolismo , Conjuntiva/patología , Factor de Crecimiento del Tejido Conjuntivo/metabolismo , Fibroblastos , Fibrosis/metabolismo , Fibrosis/prevención & control , Presión Intraocular , Masculino , Microscopía Electrónica de Transmisión , Microscopía Fluorescente , Reacción en Cadena de la Polimerasa , Conejos , Reacción en Cadena en Tiempo Real de la Polimerasa , Cápsula de Tenon/citología , Factor de Crecimiento Transformador beta1/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...